CY1124227T1 - Παστα που περιλαμβανει το μη στεροειδες αντιφλεγμονωαες φαρμακο μελοξικαμη - Google Patents

Παστα που περιλαμβανει το μη στεροειδες αντιφλεγμονωαες φαρμακο μελοξικαμη

Info

Publication number
CY1124227T1
CY1124227T1 CY20211100408T CY211100408T CY1124227T1 CY 1124227 T1 CY1124227 T1 CY 1124227T1 CY 20211100408 T CY20211100408 T CY 20211100408T CY 211100408 T CY211100408 T CY 211100408T CY 1124227 T1 CY1124227 T1 CY 1124227T1
Authority
CY
Cyprus
Prior art keywords
inflammatory drug
paste containing
steroid anti
meloxicam
drug meloxicam
Prior art date
Application number
CY20211100408T
Other languages
English (en)
Inventor
Louise Reynolds
William Blakely
Manish UMRETHIA
Original Assignee
Norbrook Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Laboratories Limited filed Critical Norbrook Laboratories Limited
Publication of CY1124227T1 publication Critical patent/CY1124227T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Μια στοματική πάστα που περιλαμβάνει: (i) τουλάχιστον ένα μη στεροειδές αντιφλεγμονώδες φάρμακο, (ii) τουλάχιστον έναν παράγοντα τροποποίησης του ιξώδους, και (iii) υγρό φορέα.
CY20211100408T 2011-10-17 2021-05-13 Παστα που περιλαμβανει το μη στεροειδες αντιφλεγμονωαες φαρμακο μελοξικαμη CY1124227T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1117858.9A GB201117858D0 (en) 2011-10-17 2011-10-17 Paste
PCT/GB2012/000790 WO2013057461A1 (en) 2011-10-17 2012-10-16 Paste comprising non-steroidal anti-inflammatory

Publications (1)

Publication Number Publication Date
CY1124227T1 true CY1124227T1 (el) 2022-05-27

Family

ID=45219794

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20211100408T CY1124227T1 (el) 2011-10-17 2021-05-13 Παστα που περιλαμβανει το μη στεροειδες αντιφλεγμονωαες φαρμακο μελοξικαμη

Country Status (17)

Country Link
US (1) US20140287048A1 (el)
EP (1) EP2768478B1 (el)
AR (1) AR088350A1 (el)
AU (1) AU2012324605B2 (el)
CA (1) CA2852613A1 (el)
CY (1) CY1124227T1 (el)
DK (1) DK2768478T3 (el)
ES (1) ES2869880T3 (el)
GB (1) GB201117858D0 (el)
HR (1) HRP20210807T1 (el)
HU (1) HUE055148T2 (el)
LT (1) LT2768478T (el)
PL (1) PL2768478T3 (el)
PT (1) PT2768478T (el)
RS (1) RS62048B1 (el)
SI (1) SI2768478T1 (el)
WO (1) WO2013057461A1 (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014116221B4 (de) 2014-11-06 2019-05-23 Ferton Holding S.A. Überwachungssystem und Verfahren zur Überwachung

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010023256A (ko) * 1997-08-27 2001-03-26 헥살 아게 용해도와 생체 이용성이 개선된 신규의 멜록시캄 의약조성물
KR100288190B1 (ko) * 1998-02-09 2001-04-16 김용규 피록시캄 함유 알콜성 하이드로겔 조성물
EP0945131A1 (de) 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Perorale Wirkstoff-Suspension
US6071523A (en) * 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
US6423697B1 (en) * 1999-01-14 2002-07-23 Mark Friedman Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm
US6924273B2 (en) * 2000-10-03 2005-08-02 Scott W. Pierce Chondroprotective/restorative compositions and methods of use thereof
KR20050007585A (ko) * 2001-06-07 2005-01-19 치오우 컨설팅, 인코포레이티드 아프타 궤양 및 단순 헤르페스 병변의 예방 및 치료조성물 및 방법
US7816366B2 (en) * 2002-02-12 2010-10-19 Asymmetric Therapeutics, Llc Compositions and methods for treating and preventing dermatoses
CA2499093A1 (en) * 2002-09-17 2004-04-01 Nippon Boehringer Ingelheim Co., Ltd. Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer.
US20050069590A1 (en) 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
EP1582221A1 (en) * 2004-03-31 2005-10-05 Chiesi S.A. Pharmaceutical oral compositions with a taste masking effect
AU2005313365A1 (en) * 2004-12-06 2006-06-15 Janssen Pharmaceutica N.V. Oral suspension comprising meloxicam
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
CA2763456C (en) * 2009-05-27 2017-10-24 Alkermes Pharma Ireland Limited Reduction of flake-like aggregation in nanoparticulate active agent compositions

Also Published As

Publication number Publication date
EP2768478B1 (en) 2021-03-17
EP2768478A1 (en) 2014-08-27
US20140287048A1 (en) 2014-09-25
PL2768478T3 (pl) 2021-10-04
LT2768478T (lt) 2021-07-12
ES2869880T3 (es) 2021-10-26
PT2768478T (pt) 2021-05-27
GB201117858D0 (en) 2011-11-30
WO2013057461A1 (en) 2013-04-25
AU2012324605B2 (en) 2017-02-23
AU2012324605A1 (en) 2014-05-29
HUE055148T2 (hu) 2021-11-29
NZ624222A (en) 2016-01-29
RS62048B1 (sr) 2021-07-30
CA2852613A1 (en) 2013-04-25
DK2768478T3 (da) 2021-05-25
AR088350A1 (es) 2014-05-28
SI2768478T1 (sl) 2021-09-30
HRP20210807T1 (hr) 2021-06-25

Similar Documents

Publication Publication Date Title
CY1124024T1 (el) Νεες ctla4-ig ανοσοπροσκολλητινες
CL2015003185A1 (es) Aparato para la electroobtención o electrorefinación
CY1117615T1 (el) Ενωσεις θειαζολης σουλφοναμιδης και οξαζολης
CO6511251A2 (es) Compuestos quimicos
DK3061454T3 (da) Parasitiske orale veterinærsammensætninger omfattende systemisk-virkende aktivstoffer, fremgangsmåder og anvendelser deraf
EA201290984A1 (ru) Гелеобразные фармацевтические композиции, препятствующие злоупотреблению
DK2139494T3 (da) Farmaceutiske formuleringer, der indeholder dapagliflozin-propylenglycolhydrat
BR112013007286A2 (pt) composição polimérica, película e bolsa de autoclave.
CL2011000481S1 (es) Aplicador para cuidado oral.
JP2011175111A5 (el)
EP3072506A4 (en) Carrier for drug delivery and conjugate, composition containing same, and method for administering same
EA201290888A1 (ru) Фармацевтическая композиция, содержащая производное пиримидинона
CL2012003523A1 (es) Método para la preparación de una composición farmacéutica que contiene un portador de oxígeno termoestable; composicion farmaceutica que contiene un portador de oxigeno altamente purificado y termoestable.
CL2013003111A1 (es) Metodo para la preparacion de una composicion farmaceutica que contiene un transportador de oxigeno purificado y termicamente estable, que contiene el transportador de oxigeno hemoglobina, donde la hemoglobina incluye a hemoglobina polimerica entrecruzada.
CY1121696T1 (el) Φαρμακευτικη συνθεση παρατεταμενης απελευθερωσης της τριμεταζιδινης
UA111324C2 (uk) Агент для профілактики або зменшення пігментації
GB201105050D0 (en) Pharmaceutical agent
CY1124227T1 (el) Παστα που περιλαμβανει το μη στεροειδες αντιφλεγμονωαες φαρμακο μελοξικαμη
CY1118277T1 (el) Σταθερη φαρμακοτεχνικη μορφη πεξιγανανης
BRPI0820361A2 (pt) Adaptador para cânulas para dispensar produtos, e cânula.
CY1114113T1 (el) Συνδυασμος ενος αναστολεα του κολπικου ρευματος if και ενος βητα-αναστολεα
FR2903887B1 (fr) Seringue perfectionnee pour administration orale.
ECSP11011212A (es) Nueva asociación de ingredientes activos que contienen un fármaco antiinflamatorio, no esteroideo y un derivado de colchicósido
IT1402606B1 (it) Dispositivo emettitore di luce.
ES1159583Y (es) Aparato de termo-retracción para el embalaje con película termo-retráctil, dotado de quemadores de secciones.